Your browser is no longer supported. Please, upgrade your browser.
ADMS Adamas Pharmaceuticals, Inc. daily Stock Chart
ADMS [NASD]
Adamas Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-4.03 Insider Own1.10% Shs Outstand27.36M Perf Week-6.42%
Market Cap143.64M Forward P/E- EPS next Y-2.42 Insider Trans-0.94% Shs Float26.99M Perf Month-12.65%
Income-111.00M PEG- EPS next Q-0.85 Inst Own79.60% Short Float6.97% Perf Quarter-1.32%
Sales51.60M P/S2.78 EPS this Y-22.80% Inst Trans11.52% Short Ratio2.92 Perf Half Y-14.36%
Book/sh0.71 P/B7.39 EPS next Y37.10% ROA-52.90% Target Price11.94 Perf Year-52.75%
Cash/sh5.49 P/C0.96 EPS next 5Y39.30% ROE-205.30% 52W Range3.35 - 12.57 Perf YTD38.52%
Dividend- P/FCF- EPS past 5Y-29.00% ROI-55.00% 52W High-59.94% Beta1.71
Dividend %- Quick Ratio6.20 Sales past 5Y-13.70% Gross Margin95.20% 52W Low50.30% ATR0.32
Employees134 Current Ratio6.30 Sales Q/Q31.10% Oper. Margin- RSI (14)43.91 Volatility6.15% 5.92%
OptionableYes Debt/Eq6.35 EPS Q/Q18.30% Profit Margin- Rel Volume0.53 Prev Close5.25
ShortableYes LT Debt/Eq6.27 EarningsFeb 25 AMC Payout- Avg Volume642.99K Price5.03
Recom2.30 SMA20-8.45% SMA50-2.65% SMA200-6.97% Volume234,168 Change-4.10%
Dec-18-19Reiterated H.C. Wainwright Buy $30 → $10
Sep-30-19Downgrade BofA/Merrill Neutral → Underperform $9 → $5
Sep-09-19Initiated Cantor Fitzgerald Neutral $8
Mar-05-19Downgrade Mizuho Neutral → Underperform $11 → $5
Nov-05-18Downgrade Mizuho Buy → Neutral
Oct-05-18Downgrade BofA/Merrill Buy → Neutral
Jul-16-18Initiated H.C. Wainwright Buy $45
Apr-04-18Initiated Leerink Partners Outperform $31
Mar-27-18Initiated BofA/Merrill Buy $39
Nov-29-17Initiated Northland Capital Outperform $70
Nov-08-17Reiterated Noble Financial Buy $33 → $48
Oct-30-17Initiated Evercore ISI Outperform $85
Sep-29-17Resumed Noble Financial Buy $33
Sep-19-17Reiterated Mizuho Buy $26 → $48
Aug-25-17Reiterated JMP Securities Mkt Outperform $29 → $33
Sep-08-16Reiterated Mizuho Buy $22 → $26
Jun-17-16Initiated Noble Financial Buy $25
Jun-16-16Upgrade Mizuho Neutral → Buy $22
May-12-16Reiterated Mizuho Neutral $17 → $16
Apr-28-16Reiterated Mizuho Neutral $14 → $17
Feb-24-20 09:02AM  Cronos (CRON) to Report Q4 Earnings: What's in the Cards? Zacks -9.33%
Feb-20-20 04:01PM  Adamas to Present at Upcoming Healthcare Conferences GlobeNewswire
Feb-19-20 04:02PM  Adamas to Announce Fourth Quarter 2019 Financial Results and Host Conference Call on February 25, 2020 GlobeNewswire
Feb-13-20 09:00AM  Adamas To Present Analysis of Clinical Trials on GOCOVRI® Treatment at the 3rd Pan American Parkinsons Disease and Movement Disorders Congress GlobeNewswire
Feb-12-20 09:18AM  The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data Benzinga +6.15%
Feb-11-20 04:15PM  Adamas Announces Publication of the Two-Year Phase 3 Open-Label EASE LID 2 Trial of GOCOVRI® for Dyskinesia in Patients with Parkinsons Disease GlobeNewswire
Feb-10-20 10:50AM  SHAREHOLDER ALERT: ADMS GDOT BYND: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:00AM  ADMS FINAL DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Reminds Adamas Pharmaceuticals, Inc. Investors of Important February 10th Deadline in Securities Class Action ADMS GlobeNewswire
09:57AM  FINAL DEADLINE ALERT - Adamas Pharmaceuticals, Inc. (ADMS) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: February 10, 2020 ACCESSWIRE
Feb-09-20 10:25AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ADMS, OPRA and PTLA ACCESSWIRE
Feb-08-20 10:30AM  ADMS FINAL DEADLINE: ROSEN, INVESTOR COUNSEL, Reminds Adamas Pharmaceuticals, Inc. Investors of Important February 10 Deadline in Securities Class Action - ADMS ACCESSWIRE
Feb-07-20 01:30PM  CLASS ACTION UPDATE for ADMS, GDOT and PTLA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:00AM  DEADLINE ALERT - Adamas Pharmaceuticals, Inc. (ADMS) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: February 10, 2020 GlobeNewswire
Feb-06-20 05:40PM  CLASS ACTION UPDATE for ADMS, SSL and BZUN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
01:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS ACCESSWIRE
Feb-05-20 06:00PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ADMS, GDOT and FSCT ACCESSWIRE
03:15PM  5-Day Deadline Alert: The Schall Law Firm Has Filed a Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:40PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ADMS, XYF and PTLA ACCESSWIRE
11:26AM  ADAMAS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Adamas Pharmaceuticals, Inc.s January 24, 2018 Secondary Public Offering To Contact The Firm GlobeNewswire
10:52AM  CLASS ACTION UPDATE for ADMS, FSCT and BYND: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
09:56AM  DEADLINE ALERT - Adamas Pharmaceuticals, Inc. (ADMS) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: February 10, 2020 ACCESSWIRE
Feb-04-20 08:40PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ADMS, FSCT and PTLA ACCESSWIRE
08:05PM  6-Day Deadline Alert: The Schall Law Firm Has Filed a Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:41PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS GlobeNewswire
12:30PM  SHAREHOLDER ALERT: ADMS PTLA GERN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
12:00PM  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. GlobeNewswire
11:12AM  INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in Adamas Pharmaceuticals, and Exelon Corporation of Filing Deadlines GlobeNewswire
10:12AM  ADMS INVESTOR ALERT: Bernstein Liebhard LLP Reminds Investors of a Filing Deadline in a Securities Class Action Against Adamas Pharmaceuticals, Inc ACCESSWIRE
Feb-03-20 03:45PM  SHAREHOLDER ALERT: ADMS GDOT PTLA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
01:45PM  NOTICE FROM FIRM THAT FILED THE LAWSUIT: The Schall Law Firm Has Filed a Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:00PM  DEADLINE ALERT for XYF, BZUN, ADMS, MHK: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:45AM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ADMS, GDOT and XYF ACCESSWIRE
10:11AM  ADMS INVESTOR DEADLINE IN 7 DAYS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Against Adamas Pharmaceuticals, Inc. Business Wire
Feb-01-20 02:17PM  ADMS INVESTOR ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Against Adamas Pharmaceuticals, Inc. ACCESSWIRE
02:00PM  ADMS FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Reminds Adamas Pharmaceuticals, Inc. Investors of Important February 10th Deadline in Securities Class Action ADMS GlobeNewswire
Jan-31-20 04:35PM  SHAREHOLDER ALERT: ADMS MMSI OPRA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
02:22PM  INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in Adamas Pharmaceuticals, and Exelon Corporation of Filing Deadlines GlobeNewswire
01:55PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS ACCESSWIRE
01:37PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS GlobeNewswire
01:15PM  CLASS ACTION UPDATE for ADMS, FCAU and GERN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:16AM  ADAMAS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Adamas Pharmaceuticals, Inc. (ADMS) To Contact The Firm Business Wire
10:20AM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ADMS, MMSI and FCAU ACCESSWIRE
09:57AM  INVESTOR ALERT: ADMS and BZUN: Bronstein, Gewirtz & Grossman LLC Alerts Shareholders With Losses Exceeding $100K of Class Action Deadlines ACCESSWIRE
Jan-30-20 01:10PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ADMS, EXC and QD ACCESSWIRE
Jan-29-20 04:40PM  ALERT FROM FIRM THAT FILED THE LAWSUIT: The Schall Law Firm Has Filed a Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS ACCESSWIRE
01:19PM  ADAMAS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Adamas Pharmaceuticals, Inc. (ADMS) To Contact The Firm GlobeNewswire
11:30AM  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. GlobeNewswire
09:00AM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against X Financial, Baozun, Adamas Pharmaceuticals, and Cintas and Encourages Investors to Contact the Firm GlobeNewswire
Jan-28-20 08:55PM  ADMS SHAREHOLDER ALERT: ROSEN, A LEADING FIRM, Reminds Adamas Pharmaceuticals, Inc. Investors of Important February 10 Deadline in Securities Class Action - ADMS ACCESSWIRE
03:10PM  NOTICE FROM FIRM THAT FILED THE LAWSUIT: The Schall Law Firm Has Filed a Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:30PM  CLASS ACTION UPDATE for ADMS, GDOT and QD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
12:13PM  ADMS LOSSES ALERT: Bernstein Liebhard LLP Encourages Investors With Losses in ADMS Exceeding 20K to Contact the Firm and Reminds Investors of a Filing Deadline in a Securities Class Action Against Adamas Pharmaceuticals, Inc ACCESSWIRE
11:47AM  ADAMAS SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Adamas Pharmaceuticals, Inc. (ADMS) To Contact The Firm Newsfile
10:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS GlobeNewswire
Jan-27-20 06:55PM  SHAREHOLDER ALERT: ADMS HEXO FCAU: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
05:06PM  INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in Adamas Pharmaceuticals, and Exelon Corporation of Filing Deadlines GlobeNewswire
01:40PM  CLASS ACTION UPDATE for ADMS, QD and GERN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:15AM  ALERT FROM FIRM THAT FILED THE LAWSUIT: The Schall Law Firm Has Filed a Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:00AM  DEADLINE ALERT for XYF, BZUN, ADMS, MHK: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:45AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ADMS, QD and GERN ACCESSWIRE
09:35AM  ADAMAS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Adamas Pharmaceuticals, Inc. (ADMS) To Contact The Firm Newsfile
Jan-26-20 07:55AM  Does Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) Have A Particularly Volatile Share Price? Simply Wall St.
Jan-24-20 05:15PM  SHAREHOLDER ALERT: ADMS REAL EXC: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE -9.32%
03:12PM  ADMS INVESTOR ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Against Adamas Pharmaceuticals, Inc. ACCESSWIRE
10:25AM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ADMS, REAL and BZUN ACCESSWIRE
10:00AM  INVESTOR ALERT: ADMS and BZUN: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders With Losses Exceeding $100K of Class Action Deadlines GlobeNewswire
Jan-23-20 05:44PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS GlobeNewswire
11:35AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ADMS, MMSI and PTLA ACCESSWIRE
11:00AM  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. GlobeNewswire
Jan-22-20 02:50PM  SHAREHOLDER ALERT: ADMS XYF BZUN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
02:00PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Baozun, Adamas Pharmaceuticals, Cintas, and Correvio Pharma and Encourages Investors to Contact the Firm GlobeNewswire
01:19PM  INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in Adamas Pharmaceuticals, and Exelon Corporation of Filing Deadlines GlobeNewswire
10:50AM  CLASS ACTION UPDATE for ADMS, BAX and MHK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
09:07AM  ADMS INVESTOR ALERT: Bernstein Liebhard LLP Encourages Investors With Losses in ADMS Exceeding 20K to Contact the Firm and Reminds Investors of a Filing Deadline in a Securities Class Action Against Adamas Pharmaceuticals, Inc ACCESSWIRE
Jan-21-20 07:05PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ADMS, BAX and MMSI ACCESSWIRE
05:50PM  ADMS INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Reminds Adamas Pharmaceuticals, Inc. Investors of Important February 10th Deadline in Securities Class Action ADMS GlobeNewswire
11:55AM  CLASS ACTION UPDATE for ADMS, GRUB and XYF: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:00AM  DEADLINE ALERT for HEXO, XYF, BZUN, ADMS: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Jan-17-20 04:55PM  SHAREHOLDER ALERT: ADMS FSCT EXC: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
03:00PM  ADMS EQUITY NOTICE: ROSEN, NATIONAL INVESTOR COUNSEL, Announces Securities Class Action Lawsuit Against Adamas Pharmaceuticals, Inc.; Important Deadline in Case - ADMS ACCESSWIRE
10:20AM  CLASS ACTION UPDATE for ADMS, MMSI and BZUN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
09:56AM  INVESTOR ALERT: ADMS and BZUN: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders With Losses Exceeding $100K of Class Action Deadlines ACCESSWIRE
12:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS GlobeNewswire
Jan-16-20 02:00PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ADMS, BZUN and EXC ACCESSWIRE
12:51PM  ADMS INVESTOR ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Against Adamas Pharmaceuticals, Inc. ACCESSWIRE
11:00AM  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. GlobeNewswire
10:45AM  SHAREHOLDER ALERT: ADMS PRU MHK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
Jan-15-20 06:55PM  ALERT FROM FIRM THAT FILED THE LAWSUIT: The Schall Law Firm Has Filed a Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
05:20PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ADMS, FCAU and BZUN ACCESSWIRE
04:32PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Baozun, Adamas Pharmaceuticals, Cintas, and Correvio Pharma and Encourages Investors to Contact the Firm GlobeNewswire
10:45AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ADMS, WSG and CGC ACCESSWIRE
Jan-14-20 10:50PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS ACCESSWIRE
07:50PM  SHAREHOLDER ALERT: ADMS FSCT HEXO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
06:15PM  ADMS INVESTOR ALERT: Bernstein Liebhard Encourages Investors With Losses in ADMS Exceeding 20K to Contact the Firm and Reminds Investors of a Filing Deadline in a Securities Class Action Against Adamas Pharmaceuticals, Inc ACCESSWIRE
04:45PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ADMS, AFI and PRU ACCESSWIRE
04:02PM  ROSEN, A LEADING LAW FIRM, Reminds Adamas Pharmaceuticals, Inc. Investors of Important February 10th Deadline in Securities Class Action ADMS GlobeNewswire
Jan-13-20 02:15PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ADMS, ET and EXC ACCESSWIRE +5.97%
02:00PM  NOTICE FROM FIRM THAT FILED THE LAWSUIT: The Schall Law Firm Has Filed a Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:13PM  INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in Adamas Pharmaceuticals, and Exelon Corporation of Filing Deadlines GlobeNewswire
Adamas Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of medicines for patients suffering from chronic neurologic disorders. The company offers GOCOVRI, an extended release capsule for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications. It is also developing ADS-5102 that is in Phase III clinical study to treat walking impairment in patients with multiple sclerosis and other indications; and ADS-4101, which has completed two Phase I studies for treating partial onset seizures in patients with epilepsy. In addition, the company offers Namzaric (memantine hydrochloride extended release and donepezil hydrochloride) capsules for the treatment of moderate to severe dementia of an Alzheimer's type. The company was formerly known as NeuroMolecular Pharmaceuticals, Inc. and changed its name to Adamas Pharmaceuticals, Inc. in July 2007. Adamas Pharmaceuticals, Inc. was founded in 2000 and is headquartered in Emeryville, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Prentiss Christopher BChief Financial OfficerJan 21Sale5.921,2697,51270,940Jan 23 05:33 PM
MERRIWEATHER ALFRED GChief Financial OfficerSep 20Sale6.911,58410,94548,019Sep 23 04:19 PM
MAHONEY DAVID LDirectorSep 17Option Exercise1.7633,33258,49857,153Sep 18 04:38 PM
Prentiss Christopher BChief Accounting OfficerJul 22Sale6.001,0826,49247,209Jul 23 06:06 PM
Rhodes Jennifer JCBO, GC & Compliance OfficerJun 20Sale5.359405,02963,114Jun 21 05:38 PM
Rhodes Jennifer JCBO, GC & Compliance OfficerMar 20Sale7.991,79214,31831,612Mar 21 04:39 PM
Went Gregory TChief Executive OfficerMar 20Sale7.996,31950,489176,291Mar 21 04:37 PM
MERRIWEATHER ALFRED GChief Financial OfficerMar 20Sale7.998576,84724,603Mar 21 04:47 PM
Patni RajivChief Medical OfficerMar 20Sale8.002,37418,99219,141Mar 21 04:45 PM
Prentiss Christopher BChief Accounting OfficerMar 20Sale8.001,1859,48029,541Mar 21 04:43 PM